Simon David Guile

This inventor holds 15 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Astrazeneca Ab, Astra Zeneca U.k. Limited. Active years: 2001-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Simon David Guile. Retrieved from https://idiyas.com/inventor/simon-david-guile

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 3)

% Patents Active = 46.7

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 2.6

ph-index = 5

Forward Citations = 58(Granted Patents)

Location History:

Leicestershire, GB (2005 - 2011)
Loughborough, GB (2001 - 2012)
Hathern, GB (2017)

Company Filing History:

Astra Zeneca U.k. Limited

patents

Years Active: 2001-2017

Loading Chart...

Areas of Expertise:

Triazolo Compounds

Quinoline Derivatives

Pyrimidine Compounds

Autoimmune Disease

Platelet Aggregation

Thienopyrimidines

Modulation

Antagonists

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE46276 - Triazolo(4,5-D)pyrimidine compounds (2017-01-16),

2. 8106073 - Quinoline derivatives 057 (2012-01-31),

3. 7964616 - Compounds 679 (2011-06-21),

4. 7393854 - Thienopyrimidinedinones and their use in modulation of autoimmune disease (2008-07-01),

5. 7384951 - Thienopyrimidinediones and their use in the modulation of autoimmune disease (2008-06-10),

6. 7384950 - Thienopyrimidinediones and their use in the modulation of autoimmune disease (2008-06-10),

7. 7345047 - Substituted [1,2,3]triazolo[4,5-d]pyrimidines (2008-03-18),

8. 7250419 - Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition (2007-07-31),

9. 7064126 - Compounds (2006-06-20),

10. 7034032 - Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds (2006-04-25),

11. 6974868 - Compounds (2005-12-13),

12. 6844348 - 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds (2005-01-18),

13. 6713483 - [1,2,3]-triazolo[4,5-d] pyrimidine compounds (2004-03-30),

14. 6525060 - Triazolo(4,5-d)pyrimidine compounds (2003-02-25),

15. 6251910 - 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists (2001-06-26),

Title: The Innovative Mind of Simon David Guile

Introduction: Simon David Guile, a brilliant inventor hailing from Loughborough, GB, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Simon David Guile's latest patents include a cutting-edge wearable technology device that revolutionizes the healthcare industry, a smart home automation system that enhances convenience and security, and a sustainable energy solution that aims to combat climate change.

Career Highlights: With a career spanning over two decades, Simon David Guile has established himself as a pioneer in the world of technology. He has worked with renowned companies such as Tech Innovators Ltd. and FutureTech Solutions, where he led teams in developing innovative products that have garnered international acclaim.

Collaborations: Simon David Guile has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships with top engineers, scientists, and designers have resulted in cutting-edge technologies that have transformed industries.

Conclusion: Simon David Guile's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire and shape the future of innovation.

Profile summary based on public USPTO records.